Gingko V and Radiotherapy Burns

A few years back, you were more than a hundred to have answered the questionnaire “Ginkgo V Questionnaire”. This number is definitely enough to be statistically significant.

From 2012 to 2030, worldwide cancer cases are projected to increase by 50% from 14 million to 21 million (World Health Organization). Worldwide cancer deaths are projected to increase by 60% from 8 million to 13 million. However, it seems that little is done to improve the treatments, or at least the comfort offered to patients, even though the problem of burns resulting from radiotherapy is well documented in the medical literature.

The medical description of tumors resulting from burns dates back to 1828 (Marjolin 1828). Sirsat and Shrikhande reported (1967) that 25% of burns induce tumors. Castillo and Goldsmith (1968) explained that immunosuppression of scar tissue predisposes to malignant degeneration. In addition, any burn inducing an alteration at the cellular level of deoxyribonucleic acid produces mutations (Clairmont et al, 1979). Kaplan (Adv Dermatol. 1987: 2: 19-46) reports: “The death rate is high: one in three or four patients with burns, osteomyelitis, or irradiated cancer dies from dermal complications”.

The Ginkgo biloba extract developed by Mirko Beljanski therefore corresponds to a real need.

It appears from your answers (97 questionnaires were fully completed and were taken into account) that Ginkgo V users see the incidence and severity of significantly reduced radiotherapy-related burns. 53 of you have reported going through the radiation therapy ordeal without any burns. 38 with the equivalent of a good sunburn. 5 cases of 2nd degree burns (with a little less than one capsule per 10 kg) 1 single case of 3rd degree burns (one person having received 117 Gray, that is twice as much radiation than normal).